Shots: The companies have expanded their clinical trial collaboration and supply agreement for IDE196 and crizotinib. The study will evaluate combination therapy in patients with solid tumors having GNAQ or […]readmore
Tags : IDEAYA
Shots: Ideaya to receive ~$100M as upfront in cash, $20M as equity investment, $50M in cash as option exercise fee for the MAT2A program and is eligible to receive preclinical, […]readmore
1. Merck Collaborates with Dragonfly to Develop and Commercialize Novel Therapies Utilizing TriNKET Platform Published: Mar 19, 2020 | Tags: Merck, Collaborates, Dragonfly, Develop, Commercialize, Novel Therapies, Utilizing, TriNKET Platform 2. […]readmore
Shots: The companies entered into a clinical trial collaboration and supply agreement to evaluate the combination of IDE196 + binimetinib for GNAQ or GNA11 hotspot mutated solid tumors, including MUM, […]readmore